These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30677265)

  • 1. A Man Made Manic: Levodopa-Carbidopa-Induced Mania in Traumatic Brain Injury.
    Sablaban IM; Sivananthan M
    Prim Care Companion CNS Disord; 2019 Jan; 21(1):. PubMed ID: 30677265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson disease treatment in hospitals and nursing facilities: avoiding pitfalls.
    Ahlskog JE
    Mayo Clin Proc; 2014 Jul; 89(7):997-1003. PubMed ID: 24996235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with motor fluctuations and dyskinesia in Parkinson Disease: potential role of a new melevodopa plus carbidopa formulation (Sirio).
    Stocchi F; Marconi S
    Clin Neuropharmacol; 2010 Jul; 33(4):198-203. PubMed ID: 20414107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treatment of Parkinson's disease].
    Baumann CR; Waldvogel D
    Praxis (Bern 1994); 2013 Dec; 102(25):1529-35. PubMed ID: 24326048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs for Parkinson's disease.
    Treat Guidel Med Lett; 2013 Nov; 11(135):101-6. PubMed ID: 24165688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. My doctor prescribed Sinemet for my restless legs and it was a catastrophe. Why did you recommend it in a recent article?
    Johns Hopkins Med Lett Health After 50; 1998 Feb; 10(12):8. PubMed ID: 9916583
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel.
    Solla P; Cannas A; Marrosu MG; Marrosu F
    Parkinsonism Relat Disord; 2015 Nov; 21(11):1383-4. PubMed ID: 26453388
    [No Abstract]   [Full Text] [Related]  

  • 9. Sinemet and brain injury: functional versus statistical change and suggestions for future research designs.
    Wolf AP; Gleckman AD
    Brain Inj; 1995 Jul; 9(5):487-93. PubMed ID: 7550220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine agonist therapy for Parkinson disease and pathological gambling.
    Imamura A; Uitti RJ; Wszolek ZK
    Parkinsonism Relat Disord; 2006 Dec; 12(8):506-8. PubMed ID: 16723269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modeling of schizophrenia with Levodopa + Carbidopa].
    Kucher EO; Egorov AIu; Chernikova NA; Filatova EV
    Zh Evol Biokhim Fiziol; 2013; 49(5):352-6. PubMed ID: 25434191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible serotonin syndrome with carbidopa-levodopa and linezolid.
    Pettit NN; Alonso V; Wojcik E; Anyanwu EC; Ebara L; Benoit JL
    J Clin Pharm Ther; 2016 Feb; 41(1):101-3. PubMed ID: 26813986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label evaluation of the tolerability and safety of Stalevo (carbidopa, levodopa and entacapone) in Parkinson's disease patients experiencing wearing-off.
    Koller W; Guarnieri M; Hubble J; Rabinowicz AL; Silver D
    J Neural Transm (Vienna); 2005 Feb; 112(2):221-30. PubMed ID: 15503197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery from vegetative state of six months' duration associated with Sinemet (levodopa/carbidopa).
    Haig AJ; Ruess JM
    Arch Phys Med Rehabil; 1990 Dec; 71(13):1081-3. PubMed ID: 2256811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of dopamine dysregulation syndrome with valproic acid.
    Epstein J; Madiedo CJ; Lai L; Hayes MT
    J Neuropsychiatry Clin Neurosci; 2014; 26(3):E3. PubMed ID: 25093777
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of controlled-release levodopa on the microstructure of sleep in Parkinson's disease.
    Wailke S; Herzog J; Witt K; Deuschl G; Volkmann J
    Eur J Neurol; 2011 Apr; 18(4):590-6. PubMed ID: 20849470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterotopic ossification following distal radius fractures in a patient with Parkinson disease treated with levodopa-carbidopa.
    Ifedi BO; Best CM; Reichel LM
    J Hand Surg Am; 2013 Jun; 38(6):1259-61. PubMed ID: 23707023
    [No Abstract]   [Full Text] [Related]  

  • 18. Parcopa: a rapidly dissolving formulation of carbidopa/levodopa.
    Med Lett Drugs Ther; 2005 Jan; 47(1201):12. PubMed ID: 15706700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy: problems and practices.
    Muenter MD
    Clin Neuropharmacol; 1986; 9 Suppl 1():S23-36. PubMed ID: 3708606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the new levodopa agent Stalevo (levodopa/carbidopa/entacapone) in the treatment of Parkinson's disease in out-patient clinical practice (the START-M open trial).
    Boiko AN; Batysheva TT; Minaeva NG; Babina LA; Vdovichenko TV; Zhuravleva EY; Shikhkerimov RK; Malykhina EA; Khozova AA; Zaitsev KA; Kostenko EV
    Neurosci Behav Physiol; 2008 Nov; 38(9):933-6. PubMed ID: 18975095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.